Bevacizumab/temozolomideLack of efficacy: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1940卷 / 1期

关键词：

D O I：

10.1007/s40278-023-31972-y

中图分类号：

学科分类号：

摘要：

引用

下载

收藏

页码：114 / 114

相关论文

共 50 条

[1] Bevacizumab/TemozolomideLack of efficacy: 2 case reports
Reactions Weekly, 2024, 2030 (1) : 98 - 98
[2] Bevacizumab/irinotecan/temozolomideLack of efficacy: 6 case reports
Reactions Weekly, 2024, 2024 (1) : 92 - 92
[3] Bevacizumab/lomustine/temozolomideLack of efficacy: 3 case reports
Reactions Weekly, 2022, 1918 (1) : 105 - 105
[4] Bevacizumab/temozolomideLack of efficacy: case report
Reactions Weekly, 2023, 1974 (1) : 80 - 80
[5] Bevacizumab/temozolomideLack of efficacy: case report
Reactions Weekly, 2023, 1950 (1) : 95 - 95
[6] Bevacizumab/TemozolomideLack of efficacy: case report
Reactions Weekly, 2024, 2030 (1) : 99 - 99
[7] Bevacizumab/temozolomideLack of efficacy: case report
Reactions Weekly, 2023, 1960 (1) : 104 - 104
[8] Bevacizumab/TemozolomideLack of efficacy
Reactions Weekly, 2024, 2006 (1) : 138 - 138
[9] Bevacizumab/temozolomideLack of efficacy
Reactions Weekly, 2024, 2011 (1) : 89 - 89
[10] TemozolomideLack of efficacy: 3 case reports
Reactions Weekly, 2022, 1922 (1) : 541 - 541

← 1 2 3 4 5 →